GARFIELD-AF landmark: first-year outcomes of 52,000 prospective patients.

Back

Open Access

GARFIELD-AF landmark: first-year outcomes of 52,000 prospective patients.

Session: Atrial fibrillation – A bystander or cause of morbidity and mortality: insights from the GARFIELD-AF registry

Topic: Atrial fibrillation (AF)

Speaker: Professor A. Kakkar (London, GB)

Sponsored by Thrombosis Research Institute

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Ajay Kakkar

Thrombosis Research Institute, London (United Kingdom of Great Britain & Northern Ireland)

13 presentations

0 follower

7 more presentations in this session

Atrial fibrillation burden: morbidity and mortality.

Speaker: Doctor S. Goldhaber (Boston, US)

Access

Slides

Video

Heart failure and atrial fibrillation: patient profile and outcomes in the real world.

Speaker: Doctor A. Turpie (Hamilton, CA)

Access

Slides

Video

Management and outcomes in acute coronary syndromes with atrial fibrillation: where can we improve?

Speaker: Professor K. Fox (Edinburgh, GB)

Access

Slides

Video

Chronic kidney disease and atrial fibrillation: geographic differences in routine care.

Speaker: Professor S. Goto (Isehara, JP)

Access

Slides

Video

Impact of body mass index and the metabolic syndrome on outcomes in atrial fibrillation.

Speaker: Professor J. Camm (London, GB)

Access

Slides

Video

Access the full session

Atrial fibrillation – A bystander or cause of morbidity and mortality: insights from the GARFIELD-AF registry

Speakers: Professor A. Kakkar, Doctor S. Goldhaber, Doctor A. Turpie, Professor K. Fox, Professor S. Goto...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources